News
Which of These 5 Will Be the Best-Selling Drug Worldwide in 2020?
The global pharmaceutical industry is a giant, in case you didn't already know it. According to a 2016 report from the International Trade Administration (ITA), global sales of pharmaceuticals are....
8 Stocks Billionaires Own
Rummage through the holdings of billionaire investors, and you're likely to find similar stocks occupying their portfolios. With so much money to invest, they can't take a meaningful position in a....
The iPhone 8's Biggest New Feature Is Less Impressive Than You Think
The new 2017 iPhones are here, and Apple (NASDAQ: AAPL) began taking pre-orders for the iPhone 8 and 8 Plus today, which starts shipping in a week. Meanwhile, the iPhone lineup is starting to look....
1 Way Apple Inc. Played It Safe With the A11 Bionic Chip
Apple's (NASDAQ: AAPL) new A11 Bionic chip that'll be at the heart of every iPhone 8, iPhone 8 Plus, and iPhone X seems like a truly incredible piece of engineering. Apple claims solid....
This Week in Solar
It was another wild week for the solar industry. There appears to be more growth than anticipated, next-generation products are starting to take off, and projects due two years from now are....
Should I Buy Travelers Stock Despite Hurricanes Harvey And Irma?
If history is our guide, then policy demand and premium pricing strength following Hurricanes Harvey and Irma could make it the perfect time to buy shares in property and casualty insurer....
3 High-Yield Dividend Stocks for September
For investors in search of income, three high-yield dividend stocks worth consideration in September include Qualcomm (NASDAQ: QCOM), IBM (NYSE: IBM) and Enterprise Products Partners (NYSE: EPD).....
Tech Stocks This Week: iPhone X, Google's Pixel 2, and Tesla's Semitruck
Thanks to Apple (NASDAQ: AAPL), this was undoubtedly a big week in tech. As the world's most valuable company, Apple's annual iPhone launches are always a big deal. But this year's September Apple....
The Smartest Move Johnson & Johnson Has Made All Year
Healthcare conglomerate Johnson & Johnson (NYSE: JNJ) is what you might call a stalwart in the portfolios of risk-averse, income-seeking long-term investors. It's about as rock-solid as they....
It Might Take a While for Android to Catch Up With Apple on 3D Sensing
One of the big new features in Apple's (NASDAQ: AAPL) iPhone X is its 3D-sensing capability, which will enable 3D facial recognition and deliver superior augmented reality (AR) experiences. The....
This Just In: Qualcomm Stock Upgraded
Every day, Wall Street analysts upgrade some stocks, downgrade others, and "initiate coverage" on a few more. But do these analysts even know what they're talking about? Today, we're taking one....
Did This Apple Inc. Supplier Fail to Deliver?
It's widely believed that Taiwan Semiconductor Manufacturing Company (NYSE: TSM), or TSMC for short, is the sole manufacturer of the A11 Bionic chip that's at the heart of the Apple (NASDAQ:....
Apple, Inc.'s iPhone Lineup Is Getting Overcrowded
For most of the iPhone's history, Apple (NASDAQ: AAPL) has offered three different tiers of iPhones. The latest and greatest always occupied the high-end price point, with the previous generation....
3 Possible Reasons Apple Inc.'s iPhone X Doesn't Have This Amazing Feature
When Apple (NASDAQ: AAPL) announced the new iPhone X, I was more than a little disappointed to learn that the new phone doesn't include Apple's ProMotion display technology found on the 10.5- and....
Why Investors Are Paying a Premium for Costco Stock
Many investors are avoiding the retailing industry as if it were an out-of-favor strip mall. Wall Street is worried that the latest shopper traffic slowdown is just the beginning of a long,....
Disney World's Top Rival Tries to Scare Its Way to the Top
Halloween is a special time of year for Comcast's (NASDAQ: CMCSA) Universal Orlando. Halloween Horror Nights 27 kicks off tonight, greeting as many as tens of thousands of guests on select event....
Better Buy: Infinera Corporation vs. Ciena Corporation
Infinera (NASDAQ: INFN) and Ciena (NYSE: CIEN) were both market laggards this year, with the former staying nearly flat and the latter dropping almost 10%. Both optical transport solution....
After iPhone X, What’s Next for Apple Inc. Stock?
Now that Apple (NASDAQ: AAPL) has finally announced its highly anticipated iPhone X smartphone, current and potential investors in Apple are probably keenly interested in where the stock will head....
Here's Why Higher Interest Rates Matter to JPMorgan Chase
Interest rates are one of the most important catalysts for bank stocks right now, with higher rates promising improved profitability throughout the industry. Given that the Federal Reserve will....
Apple Inc. May Have Finally Solved a Big iPhone X Production Problem
On Sept. 12, Apple (NASDAQ: AAPL) unveiled its new iPhone X (pronounced "iPhone 10") smartphone. The device is Apple's best -- and most premium -- smartphone to date, sporting a nifty 3D sensing....
Pfizer Punches Back at Johnson & Johnson in Prostate Cancer
After winning Food and Drug Administration (FDA) approval for use in castration-resistant metastatic prostate cancer in 2012, Pfizer's (NYSE: PFE) Xtandi quickly gained ground on Johnson &....
3 Value Stocks for Nest-Egg Growth
Stock investing can be volatile, creating short-term risk. But if you invest in stocks at their best value points, you can reduce some of the risk and set yourself up for better long-term returns.....
3 High-Yield Stocks Still Worth Buying
High yields on a stock can often be a warning sign for investors, indicating the market doesn't think the high payout will last long. But the market can sometimes assign too much risk to....
2 Features to Expect From Apple Inc.’s Next iPhone X
On Sept. 12, Apple (NASDAQ: AAPL) finally unveiled its long-awaited premium iPhone, which we now know is called the iPhone X. The phone is -- at least from what I've seen from Apple's....
Who Will Win the Kidney Cancer Battle Between Bristol-Myers Squibb and Exelixis?
A head-to-head competition for market share in the renal cell carcinoma (RCC) market appears to be about to intensify. In one corner is Bristol-Myers Squibb (NYSE: BMY). With a market cap of over....